Transcript mozambique

PHARMACOVIGILANCE SYSTEM - MOZAMBIQUE
INTRODUCING PV INTO HIV/AIDS
PROGRAMME
Sevene E, Mariano A, Mola D
Faculty of Medicine / Ministry of Health
Pretoria, September 2004
PHARMACOVIGILANCE SYSTEM - MOZAMBIQUE
INTRODUCTION
•Population: 19 million
•Prevalence of HIV: 14%
•The highest prevalence (20%) is found
along the central Provinces
•An estimated 1.2 million Mozambicans are
living with HIV
•290,000 of them with AIDS.
PHARMACOVIGILANCE SYSTEM - MOZAMBIQUE
INTRODUCTION
•83,000 people died of AIDS-related
diseases in 1997
•As a result of HIV/AIDS infection, life
expectancy will decrease to 37 years if no
treatment available
•20 Day Hospitals are available
•40,000 patients registered in Day Hospitals
•Only 4,000 are on ARVT
PHARMACOVIGILANCE SYSTEM - MOZAMBIQUE
INTRODUCTION
•Introduction of the ARVT is crucial
•Need of PV systems to monitor the new drugs
•Proposal of PV system in Mozambique was
developed in order to be implemented in
collaboration with diseases control programmes
(malaria, HIV/AIDS, TB, immunization) to achieve
the goal of monitoring all drugs in the market
•Safety monitoring of all drugs is a public health
need
PHARMACOVIGILANCE SYSTEM - MOZAMBIQUE
OBJECTIVES OF THE SYSTEM
•Detect and report ADR
•Assess signals to evaluate causality
•Assess the risk-benefit profile and
implications to public health
•Prevention of ADR by promoting rational
drug use
•Communicate and recommend to authorities
and the public
•Recommend appropriate response or action
PHARMACOVIGILANCE SYSTEM - MOZAMBIQUE
WHO SHOULD REPORT
•All Health Professionals
Medical doctors
Pharmacists
Health technicians
Nurses
Care providers
•Patients…
PHARMACOVIGILANCE SYSTEM - MOZAMBIQUE
WHAT SHOULD BE REPORTED?
•All suspected ADR (including non serious)
•For new drugs/combinations (anti-malarial,
ARV, anti-TB) should be reported all
suspected event
•An increase of frequency of known ADR
•Treatment failure
SUSPECT
REPORT
PHARMACOVIGILANCE SYSTEM - MOZAMBIQUE
HOW SHOULD MONITORING ACCUR?
•Spontaneous report
•ADR report form will be available in
the health facilities.
•The filled form should be sent to
CIMed according to the flow of
information.
•Cohort studies
•Selected sites
•Needs investigators collaboration
PHARMACOVIGILANCE SYSTEM - MOZAMBIQUE
WHAT DOES THE REPORTER RECEIVE?
•A acknowledgement letter of the
reception of the report
•Report of causality assessment
•A drug information bulletin
•A new report form
•Drug information when requested
PHARMACOVIGILANCE SYSTEM - MOZAMBIQUE
WHAT HAPPEN WITH THE REPORT IN CIMed?
•Assess causality
•Investigation by investigators team
and/or Therapeutic Committee.
•Information about the report will be
sent to the reporter.
•Make decision about the drug (DP)
•Report regularly to DCP
Patient flow
Report flow
Feedback
Information
flow
Patient/Public
Trad. Healers
C. Leaders
District Health Center
Out Patient
Hospital Rural/General
Provincial/Central
Investigation
team
pMTCT
VCT
Private
Sector
Day Hospital (DH)
DH
Chief Pharmacist
CIMed
CTTF
MOH
Education Pharmaceutical
Depart.
Depart.
Media
Importers/Industry
DCP
UMC
WHO
PHARMACOVIGILANCE SYSTEM - MOZAMBIQUE
WHAT ARE THE RESOURCES AVAILABLE?
1. Pharmacovigilance center already exist
2. Disease control programme have started
implementing their action plans
3. The 3 by 5 initiative
PHARMACOVIGILANCE SYSTEM - MOZAMBIQUE
WHAT ARE THE CRITICAL SUCCESS FACTOR?
1. Lack of Human Resources
2. Coordination
CIMed
Programmes
Health Providers
3. Training health professionals
4. Stimulate reporting
PV Training plan- Mozambique
Title
Training of trainers in Pharmacovigilance
Objectives
Recognize, manage and report ADRs and develop a
training plan
Contents
Pharmacovigilance/ARVs safety issues
Target group
Health professionals (medical Doctors, Pharmacists,
nurses)
Duration
5 Days
Methodology
Lecture, group discussion, role play, case study, plenary
discussion
Evaluation
Daily summarization at the end of each day on group
basis
Evaluation forms which includes (strength, weakness,
suggestion)
Follow up
By focal person, Quality site visits
PHARMACOVIGILANCE SYSTEM - MOZAMBIQUE
OBRIGADA
(thank you)